5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Seoul St. Mary's Hospital
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Yoo-Jin Kim, Seoul St. Mary's Hospital
ClinicalTrials.gov Identifier:
NCT01652781
First received: July 11, 2012
Last updated: November 18, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)